Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Impact of the COVID-19 Pandemic on Primary Care Access for Patients with Hematologic Malignancies

Ying Ling, Kelvin Chan, Aditi Patrikar, Ning Liu, Aisha Lofters, Colleen Fox, Simron Singh, Matthew Cheung

Blood (2021) 138 (Supplement 1): 4011.

https://doi.org/10.1182/blood-2021-154227

Published: 2021

Journal Articles

Incidence of Mental Health Events and Its Association with Survival Among Patients with Diffuse Large B-Cell Lymphoma: A Population-Based Cohort Study

Inna Gong, Matthew Cheung, Kelvin Chan, Sumedha Arya, Neil Faught, Ning Liu, Oreofe O. Odejide, Gregory A. Abel, Michael Raphael, Anca Prica, Christopher Booth, Thomas M. Kuczmarski, Lee Mozessohn

Blood (2021) 138 (Supplement 1): 1969.

https://doi.org/10.1182/blood-2021-149469

Published: 2021

Journal Articles

Outcomes of Patients with Indolent Lymphoma Treated with Bendamustine Plus Rituximab Compared to Rituximab Plus CVP or CHOP Chemoimmunotherapy in Ontario

Adam Suleman, Suriya Aktar, Ning Liu, Kelvin Chan, Matthew Cheung, Anca Prica

Blood (2021) 138 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2021-148982

Published: 2021

Journal Articles

The Impact of Marginalization on Diffuse Large B-Cell Lymphoma Overall Survival: A Retrospective Cohort Study

Sumedha Arya, Lee Mozessohn, Inna Gong, Neil Faught, Ning Liu, Simron Singh, Kelvin Chan, Matthew Cheung

Blood (2021) 138 (Supplement 1): 341.

https://doi.org/10.1182/blood-2021-146642

Published: 2021

Journal Articles

Cost-Effectiveness and Cost-Utility Analysis of ABVD Versus Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma

Abi Vijenthira, MD, Kelvin Chan, MD PhD, Matthew Cheung, MD MS, FRCP, Anca Prica, MD

Blood (2018) 132 (Supplement 1): 2248.

https://doi.org/10.1182/blood-2018-99-113103

Published: 2018

Journal Articles

Examining Convergent Construct Validity and Inter-Rater Reliability Between ESMO-MCBS and ASCO-VF When Evaluating Hematologic Malignancies

Matthew Cheung, MD MS, FRCP, Ihsan Albakri, Robert Mason, Ronak Saluja, Sierra Cheng, Vanessa Arciero, Louis Everest, Kelvin Chan, MD PhD

Blood (2018) 132 (Supplement 1): 4800.

https://doi.org/10.1182/blood-2018-99-119631

Published: 2018

Journal Articles

Improved Survival in Overweight and Obese Patients with Non-Hodgkin's Lymphoma Treated with Rituximab Containing Chemotherapy for Curative Intent

James K R Stevenson, MD MSc, Lucy Qiao, MS, MPH, Kelvin Chan, MD PhD, Jaclyn Beca, MSc, Wanrundee Isaranuwatchai, PhD, Helen Guo, BS, Deborah Schwarz, PhD, Jessica Arias, BA, MACP, Scott Gavura, BSPharm, MBA, C. Tom Kouroukis, MDMSc,FRCPC, Matthew Cheung, MD MS, FRCP

Blood (2017) 130 (Supplement 1): 1557.

https://doi.org/10.1182/blood.V130.Suppl_1.1557.1557

Published: 2017

Journal Articles

HBV Care Map for Patients Receiving Anti-CD20 Therapy

Zachary Liederman, MD, Neil Berinstein, MD, Michael Crump, MD, Jessica Hwang, MD MPH, Harry L.A. Janssen, PhD MD, C. Tom Kouroukis, MDMSc,FRCPC, Patricia Leung, Anna Lok, MD, Colina Yim, Andrew D. Zelenetz, MD PhD, Kelvin Chan, MD PhD, Jordan Feld, MD MPH, Lisa K. Hicks, MD MSc

Blood (2017) 130 (Supplement 1): 4697.

https://doi.org/10.1182/blood.V130.Suppl_1.4697.4697

Published: 2017

Journal Articles

ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis

Abi Vijenthira, MD, Matthew C Cheung, MD, Chai Wye Phua, MD, Kelvin Chan, Joanna Graczyk, MD, Rena Buckstein, MD, Anca Prica, MD

Blood (2016) 128 (22): 1183.

https://doi.org/10.1182/blood.V128.22.1183.1183

Published: 2016

Journal Articles

Assessment of Value Using the American Society of Clinical Oncology (ASCO) and European Society of Medical Oncology (ESMO) Frameworks for Novel Therapies for the Hematologic Malignancies

Matthew C Cheung, MD SM, FRCPC, Sierra Cheng, Erica McDonald, Vanessa Arciero, Mahin Qureshi, Kelvin Chan

Blood (2016) 128 (22): 3578.

https://doi.org/10.1182/blood.V128.22.3578.3578

Published: 2016

Journal Articles

G-CSF as Secondary Prophylaxis of Febrile Neutropenia In the Management of Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Decision Analysis.

Joanna Graczyk, MD, Matthew Cheung, MD, Rena Buckstein, Kelvin Chan, MD

Blood (2010) 116 (21): 3831.

https://doi.org/10.1182/blood.V116.21.3831.3831

Published: 2010

NARROW

Impact of the COVID-19 Pandemic on Primary Care Access for Patients with Hematologic Malignancies

Incidence of Mental Health Events and Its Association with Survival Among Patients with Diffuse Large B-Cell Lymphoma: A Population-Based Cohort Study

Outcomes of Patients with Indolent Lymphoma Treated with Bendamustine Plus Rituximab Compared to Rituximab Plus CVP or CHOP Chemoimmunotherapy in Ontario

The Impact of Marginalization on Diffuse Large B-Cell Lymphoma Overall Survival: A Retrospective Cohort Study

Cost-Effectiveness and Cost-Utility Analysis of ABVD Versus Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma

Examining Convergent Construct Validity and Inter-Rater Reliability Between ESMO-MCBS and ASCO-VF When Evaluating Hematologic Malignancies

Improved Survival in Overweight and Obese Patients with Non-Hodgkin's Lymphoma Treated with Rituximab Containing Chemotherapy for Curative Intent

HBV Care Map for Patients Receiving Anti-CD20 Therapy

ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis

Assessment of Value Using the American Society of Clinical Oncology (ASCO) and European Society of Medical Oncology (ESMO) Frameworks for Novel Therapies for the Hematologic Malignancies

G-CSF as Secondary Prophylaxis of Febrile Neutropenia In the Management of Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Decision Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only